An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening
Antiviral Research Aug 18, 2017
Nelson EV, et al. – Researchers developed an RNA polymerase II (pol II) driven Ebola virus minigenome system to improve upon established T7 driven systems. They identified the pol II system as efficient and more versatile than the T7 systems, with applications in a wider range of cell types. It provided a biologically relevant tool for studying Ebola virus replication and transcription. It could be scaled up easily for use in cost effective antiviral drug screens.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries